Search For "biologics"
Samsung Biologics to supply Moderna vaccines in earnest, to become K-bio '
Updated : 4 years, 4 months ago IST
Seoul [South Korea], October 27 (ANI/Global Economic): Moderna's COVID-19 vaccine produced by Samsung Biologics will be supplied domestically and globally, allowing Korea to solidify its position as a global COVID-19 vaccine hub.
Read More
S Korea: Samsung Biologics begins production of Moderna COVID-19 vaccine
Updated : 4 years, 5 months ago IST
Seoul [South Korea], October 14 (ANI/Global Economic): Samsung Biologics has begun production of Moderna COVID-19 vaccine and secured supplies before GMP approval.
Read More
SII announces strategic partnership with Biocon Biologics
Updated : 4 years, 5 months ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
Read More
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sep 17 (ANI): Biocon Biologics Ltd (BBL) and Serum Institute Life Sciences (SILS) have announced a strategic alliance in a bid to make a significant impact on global healthcare through vaccines and biologics.
Read More
Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], September 17 (ANI): Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS) announced a strategic alliance on Thursday and BBL said it will offer around 15 per cent stake to SILS at a post-money valua
Read More
Bharat Biotech's US partner, Ocugen to apply for full approval for Covaxin
Updated : 4 years, 9 months ago IST
Pennsylvania [US], June 11 (ANI): Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Application (BL
Read More
Moderna's research cooperation with Korea. Will it speed up the developmen
Updated : 4 years, 9 months ago IST
Seoul [South Korea], May 25 (ANI/Global Economic): During the ROK-US summit, the attention is focused on whether the government will foster the development of domestic mRNA vaccines by laying the foundation for research cooperation with Moderna along with the consignment production of Modern
Read More
South Korea: Domestic production of Pfizer vaccine? Samsung Bio and Pfizer
Updated : 4 years, 10 months ago IST
Seoul [South Korea], May 13 (ANI/Global Economic): Even though Samsung Biologics denied reports that Pfizer's novel coronavirus infection (COVID-19) vaccine is being produced on terms of the contract manufacturing organization (CMO), observations that the possibility cannot be ruled out are
Read More
Pfizer, BioNTech seek full approval of COVID-19 vaccine across US
Updated : 4 years, 10 months ago IST
Washington [US], May 7 (ANI): Pharmaceutical giants Pfizer and BioNTech on Friday said that they have started the process for getting the US Food and Drug Administration (FDA) complete authorisation of its COVID-19 vaccine after having emergency use authorization for almost five months.
Read More
Biocon Biologics promotes Shreehas Tambe as Deputy CEO
Updated : 5 years ago IST
Bengaluru (Karnataka) [India], Mar 1 (ANI): Biocon Biologics said on Monday that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer.
Read More
Biocon Biologics partners with IDF to promote diabetes care
Updated : 5 years ago IST
Bengaluru (Karnataka) [India], February 16 (ANI): Biocon Biologics has partnered with the International Diabetes Federation (IDF) as the first biosimilar insulin company to promote and support IDF's core mission initiative and activities.
Read More
Premature birth can be reduced by treating fetus as patient: Study
Updated : 5 years, 1 month ago IST
Texas [US], January 23 (ANI): A new study by scientists of the University of Texas Medical Branch (UTMB) successfully proved the potential for reducing pre-term birth by treating a fetus as a patient with a new drug delivery system developed by ILIAS Biologics, Inc.
Read More